BRLI. IncellDx, Inc. Announces an Agreement with BioReference Laboratories, Inc. to Conduct a 10,000 Sample Study Using a Slideless Pap Smear Incell3Dx™ technology could revolutionize the $5 Billion Pap smear industry http://finance.yahoo.com/news/incelldx-inc-announces-agreement-bioreference-110000164.html stockcharts.com/c-sc/sc?s=BRLI&p=W&yr=1&mn=0&dy=0&i=t08082903514&r=1347448163819